24 institutional investment managers reported PTHS positions in their Form 13F filings for Q2 2026, holding 1,361,286 shares worth $38.5M in total. AIGH Capital Management LLC reported the largest position.

Are funds buying or selling PTHS?

In Q2 2026, 10 managers opened new PTHS positions, 7 added, 2 trimmed and 3 sold out. Managers that filed in both quarters added a net 448,975 shares.

How current is this PTHS institutional ownership data?

It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

Funds · PTHS

Who owns PTHS?

Institutional ownership of Pelthos Therapeutics Inc. from Form 13F, Q2 2026

24 institutional managers reported holding Pelthos Therapeutics Inc. (PTHS) in Form 13F filings for Q2 2026, with 1,361,286 shares worth $38.5M. The largest reported holder was AIGH Capital Management LLC. Managers that filed both quarters added a net 448,975 shares (+49.2%). 10 opened new positions and 3 sold out.

Funds holding: 24
Value held: $38.5M
New / sold out: 10 / 3
Net shares, same filers: +49.2%

Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

Largest holders of PTHS

Fund	Value	Share of 13F holdings	Shares	Move
AIGH Capital Management LLC	$9.3M	24.2%	329,098	New
Murchinson Ltd.	$8.6M	22.4%	304,302	Added
Ikarian Capital, LLC	$7.3M	18.8%	256,598	Unchanged
Boothbay Fund Management, LLC	$2.9M	7.5%	101,976	Added
Vanguard Capital Management LLC	$2.7M	7.1%	97,134	Added
Cantor Fitzgerald, L. P.	$2.2M	5.6%	76,246	Added
J. Goldman & Co LP	$1.1M	2.8%	38,075	Trimmed
Diadema Partners LP	$700K	1.8%	24,773	Unchanged
Wexford Capital LP	$632K	1.6%	22,364	New
Knott David M Jr	$624K	1.6%	22,073	Added
Citadel Advisors LLC	$425K	1.1%	15,046	New
Geode Capital Management, LLC	$414K	1.1%	14,650	Trimmed
Pale Fire Capital SE	$365K	0.9%	12,919	Unchanged
1492 Capital Management LLC	$293K	0.8%	10,380	New
Vanguard Fiduciary Trust Co	$279K	0.7%	9,873	Added
State Street Corp	$277K	0.7%	9,800	New
Persistent Asset Partners Ltd	$170K	0.4%	6,007	Unchanged
BlackRock, Inc.	$150K	0.4%	5,324	New
UBS Group AG	$63K	0.2%	2,217	Added
China Universal Asset Management Co., Ltd.	$61K	0.2%	2,160	New
Tower Research Capital LLC (TRC)	$6K	0.0%	205	New
Farther Finance Advisors, LLC	$1K	0.0%	40	Unchanged
Barclays PLC	$565	0.0%	20	New
Royal Bank of Canada	$170	0.0%	6	New

Share of 13F holdings is each fund's shares as a share of the 1,361,286 PTHS shares all 13F filers reported, not of shares outstanding.

Biggest buyers in Q2 2026

AIGH Capital Management LLC New+$9.3M
Cantor Fitzgerald, L. P. Added+$984K
Wexford Capital LP New+$632K
Boothbay Fund Management, LLC Added+$569K
Citadel Advisors LLC New+$425K
1492 Capital Management LLC New+$293K
State Street Corp New+$277K
Murchinson Ltd. Added+$226K
BlackRock, Inc. New+$150K
Vanguard Capital Management LLC Added+$114K

Biggest sellers in Q2 2026

J. Goldman & Co LP Trimmed-$349K
Steward Partners Investment Advisory, LLC Sold out-$40K
Geode Capital Management, LLC Trimmed-$18K
Aspect Partners, LLC Sold out-$336
Citigroup Inc Sold out-$21

The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $13.1M and sold $407K; 7 added and 2 trimmed.

Schedule 13D and 13G filings on PTHS

Owners of more than 5% must file within days, so these can be newer than the 13F data.

2025-11-14Murchinson Ltd. SCHEDULE 13G filed by Pelthos Therapeutics Inc.Schedule 13G
2025-07-083i, LP SCHEDULE 13G filed by Channel Therapeutics CorporationSchedule 13G
2025-07-03LIGAND PHARMACEUTICALS INC SCHEDULE 13D filed by Channel Therapeutics CorporationSchedule 13D
2025-02-14Ikarian Capital, LLC SCHEDULE 13G filed by Channel Therapeutics CorporationSchedule 13G

Questions about PTHS ownership

Who owns PTHS stock?: 24 institutional investment managers reported PTHS positions in their Form 13F filings for Q2 2026, holding 1,361,286 shares worth $38.5M in total. AIGH Capital Management LLC reported the largest position.
Are funds buying or selling PTHS?: In Q2 2026, 10 managers opened new PTHS positions, 7 added, 2 trimmed and 3 sold out. Managers that filed in both quarters added a net 448,975 shares.
How current is this PTHS institutional ownership data?: It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to PTHS by CUSIP. Options are left out. PTHS news and filings · PTHS insider trades · Top funds